LIGAND PHARMACEUTICALS INC (LGND)
Pharmaceutical Preparations · Healthcare · $5.1B
Intrinsic Value (Consensus)
$70.28
Current Price
$255.25
Margin of Safety
-72.5%
72.5% Above Intrinsic Value
Value: $70
Price: $255
Valuation Model Estimates
Current Price: $255.25
DCF (Discounted Cash Flow)
$38.42
Graham Number
$83.69
Earnings Power Value
$59.51
Relative Value (P/E)
$122.60
Dividend Discount Model
$47.17
Consensus Value
$70.28
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
65
Profitability
18/25
Strength
24/25
Valuation
7/25
Growth
16/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $6.13
- EPS (Forward)
- $6.44
- Book Value
- $50.79
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 12.2%
- Debt/Equity
- 3%
- Revenue Growth
- 60.4%
- Earnings Growth
- 5.0%
- Dividend Yield
- 2.0%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance